Send mail to Author

A randomized phase IIa trial with temsirolimus versus sunitinib in advanced non-clear cell renal cell carcinoma: an intergroup study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____     ______    ______   _    _    ______     _____   
 |__  //   /_   _//  /_____// | || | || |      \\  |  ___|| 
   / //     -| ||-   `____ `  | || | || |  --  //  | ||__   
  / //__    _| ||_   /___//   | \\_/ || |  --  \\  | ||__   
 /_____||  /_____//  `__ `     \____//  |______//  |_____|| 
 `-----`   `-----`   /_//       `---`   `------`   `-----`  
                     `-`
 


Back to frontdoor view

OPUS4 Logo